Skip to main content
. 2022 Aug 11;22:541. doi: 10.1186/s12888-022-04184-8

Fig. 3.

Fig. 3

Age-specific period prevalence of patients with major depressive disorder by first-line treatment for those who received treatment for the period 2017–2018, by relative distribution of the prevalent cohort, n = 4596. TCA, tricyclic antidepressants; SSRI, selective serotonin reuptake inhibitors